Heme Oxygenase-1-Generated Biliverdin Ameliorates Experimental Murine Colitis
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Heme oxygenase-1 (HO-1) seems to have an important protective role in acute and chronic inflammation. The products of heme catalysis, biliverdin/bilirubin, carbon monoxide (CO), and iron (that induces apoferritin) mediate the beneficial effects of HO-1. Blockade of HO-1 activity results in exacerbation of experimental colitis. We tested whether HO-1 has protective effects in the development of colitis and determined that specific enzymatic products of HO-1 are responsible for these effects. METHODS: Colitis was induced by oral administration of dextran sodium sulfate (5%) to C57BL/6 mice for 7 days. HO-1 was up-regulated by cobalt-protoporphyrin (5 mg/kg, intraperitoneally). Biliverdin, exogenous CO, or the iron chelator desferrioxamine was administered to other groups. RESULTS: Cobalt-protoporphyrin treatment resulted in significant up-regulation of HO-1 protein in mucosal and submucosal cells. Induction of HO-1 was associated with significantly less loss of body weight in mice with induced colitis (-12% versus -22% in the control animals, P < 0.001). Development of diarrhea and gastrointestinal hemorrhage was substantially delayed in animals in which HO-1 was induced, and mucosal injury was significantly attenuated. Administration of CO or desferrioxamine alone had no significant effects, whereas enhanced protection with lesser evidence of bowel inflammation was observed with systemic biliverdin administration (50 micromol/kg, 3 times per day, intraperitoneally). CONCLUSIONS: We conclude that heightened HO-1 expression or administration of biliverdin ameliorates dextran sodium sulfate-induced experimental colitis. Novel therapeutic strategies based on HO-1 and/or biliverdin administration may have use in inflammatory bowel disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Choi, A. M., & Alam, J. (1996) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.15.1.8679227 · Cited by 1,126
Carbon Monoxide Generated by Heme Oxygenase 1 Suppresses Endothelial Cell Apoptosis
Brouard, S., Otterbein, L. E., Anrather, J., Tobiasch, E., Bach, F. H., Choi, A. M. K., & Soares, M. P. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.7.1015 · Cited by 984 · cited 1×
“the antiapoptotic effect of HO-1 can, in at least some situations, also be mimicked by exogenous administration of the iron chelator, DFO, or by overexpression of the heavy chain of ferritin.(24,25) Expression of HO-1 is associated with upregulation of ferritin, which is thought to contribute, in a critical manner, to…”
BackgroundSelf-citationRichardson, D. R., & Ponka, P. (1998) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(98)90180-9 · Cited by 126 · cited 1×
“Further experiments with intracellular active iron chelators such as salicylaldehyde isonicotinyl hydrazone or the use of adenoviral-mediated expression of heavy chain apoferritin may shed further light on this issue.(39,40) CO had no cytoprotective effects in the dose range we had previously used in other inflammator…”
BackgroundRat liver cytochrome P-450b, P-420b, and P-420c are degraded to biliverdin by heme oxygenase
Kutty, R. K., Daniel, R. F., Ryan, D. E., Levin, W., & Maines, M. D. (1988) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(88)90492-4 · Cited by 95
Cited by
Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential
Paine, A., Eiz-Vesper, B., Blasczyk, R., & Immenschuh, S. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.07.014 · Cited by 699
A protective role of nuclear factor-erythroid 2-related factor-2 (Nrf2) in inflammatory disorders
Kim, J., Cha, Y.-N., & Surh, Y.-J. (2010) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2009.09.007 · Cited by 685
Friedman, D. J., Künzli, B. M., A-Rahim, Y. I., Sevigny, J., Berberat, P. O., Enjyoji, K., Csizmadia, E., Friess, H., & Robson, S. C. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902869106 · Cited by 284
Self-citationMegías, J., Busserolles, J., & Alcaraz, M. J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707184 · Cited by 117
Zhang, Z., Song, Y., Zhang, Z., Li, D., Zhu, H., Liang, R., Gu, Y., Pang, Y., Qi, J., Wu, H., et al. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16655814 · Cited by 89
“CoPP was administered by intraperitoneal injection at 5mg/kg 24 h before collagenase injection and then once daily for 1, 3, or 7 days.(20,21) ZnPP injections(22) were administered by intraperitoneal injection at 5mg/kg 2 h after collagenase injection and then once daily for 1, 3, or 7 days.”
Method
Metadata
- Authors
- Berberat, P. O., A-Rahim, Y. I., Yamashita, K., Warny, M. M., Csizmadia, E., Robson, S. C., & Bach, F. H.
- Venue
- Inflammatory Bowel Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-04
- Volume
- 11
- Issue
- 4
- Pages
- 350-359
- ISSN
- 1078-0998 (ISSN-L)
- OpenAlex
- W2056013076
- Cited by
- 114
- References
- 4
- FWCI
- 1.96
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Heme Oxygenase-1-Generated Biliverdin Ameliorates Experimental Murine Colitis. https://app.cochat.ai/papers/10.1097/01.mib.0000164017.06538.8a
- The paper
- Berberat, P. O., A-Rahim, Y. I., Yamashita, K., Warny, M. M., Csizmadia, E., Robson, S. C., & Bach, F. H. (2005). Heme Oxygenase-1-Generated Biliverdin Ameliorates Experimental Murine Colitis. Inflammatory Bowel Diseases. https://doi.org/10.1097/01.mib.0000164017.06538.8a
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.